ITPR3 and prostate carcinoma: Downregulation of IP3R3 (inositol 1,4,5-trisphosphate receptor type 3) has been proposed to be oncogenic by promoting proapoptotic mitochondrial Ca2+ transfer in breast and prostate cancer [56, 57].